These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24612897)

  • 1. Best practices to minimize risk of infection with intrauterine device insertion.
    Caddy S; Yudin MH; Hakim J; Money DM; ;
    J Obstet Gynaecol Can; 2014 Mar; 36(3):266-274. PubMed ID: 24612897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent Pregnancy Guidelines.
    Fleming N; O'Driscoll T; Becker G; Spitzer RF;
    J Obstet Gynaecol Can; 2015 Aug; 37(8):740-756. PubMed ID: 26474231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.
    Turok DK; Eisenberg DL; Teal SB; Keder LM; Creinin MD
    Am J Obstet Gynecol; 2016 Nov; 215(5):599.e1-599.e6. PubMed ID: 27180886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intrauterine contraception: CNGOF Contraception Guidelines].
    Vidal F; Paret L; Linet T; Tanguy le Gac Y; Guerby P
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):806-822. PubMed ID: 30429071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing pelvic infection after abortion.
    Stevenson MM; Radcliffe KW
    Int J STD AIDS; 1995; 6(5):305-12. PubMed ID: 8547409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection risk and intrauterine devices.
    Martínez F; López-Arregui E
    Acta Obstet Gynecol Scand; 2009; 88(3):246-50. PubMed ID: 19172421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of early-onset neonatal group B streptococcal disease.
    Money D; Allen VM;
    J Obstet Gynaecol Can; 2013 Oct; 35(10):939-948. PubMed ID: 24165063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic prophylaxis for intrauterine contraceptive device insertion.
    Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2001; (2):CD001327. PubMed ID: 11405986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for sexually transmitted infections at intrauterine device insertion: an evidence-based approach.
    Sufrin CB; Averbach SH
    Clin Obstet Gynecol; 2014 Dec; 57(4):682-93. PubMed ID: 25222531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical versus laboratory screening for sexually transmitted infections prior to insertion of intrauterine contraception among women living with HIV/AIDS: a randomized controlled trial.
    Kakaire O; Byamugisha JK; Tumwesigye NM; Gemzell-Danielsson K
    Hum Reprod; 2015 Jul; 30(7):1573-9. PubMed ID: 25979373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic prophylaxis in gynaecologic procedures.
    Van Eyk N; van Schalkwyk J;
    J Obstet Gynaecol Can; 2012 Apr; 34(4):382-391. PubMed ID: 22472341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pratiques optimales en vue de minimiser le risque d'infection au moment de l'insertion d'un dispositif intra-utérin.
    Caddy S; Yudin MH; Hakim J; Money DM
    J Obstet Gynaecol Can; 2016 Dec; 38(12S):S407-S417. PubMed ID: 28063552
    [No Abstract]   [Full Text] [Related]  

  • 19. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues of pelvic inflammatory disease in intrauterine device users: a result of the intrauterine device or Chlamydia trachomatis infection?
    Guderian AM; Trobough GE
    Am J Obstet Gynecol; 1986 Mar; 154(3):497-503. PubMed ID: 3513579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.